Cincinnati Eye News Today

Grayson Naff, from Tipp City, was diagnosed with Batten disease last year - a group of rare genetic conditions that cause the brain to gradually shut down over five to ten years.

Batten disease affects about one in 25,000 babies and eventually sufferers lose the ability to speak, move, see and swallow, developing devastating dementia

The pediatric nurse focuses on giving— to family, friends, and patients—despite a lifetime of struggle.

ST. LOUIS--(BUSINESS WIRE)--Jul 19, 2023--

Grayson Naff is 7½ years old. He’s in first grade. He lives in Tipp City. He loves his 22-month-old brother Beckett, video games, YouTube and his frie

Media release - Wednesday, April 19, 2023 Alcon Bolsters Leading Global Research and Development Team with Addition of Dr. Daniel M. Miller ... | April 19, 2023

Louis Jahnigen was one of the first two people to receive corneal cross linking, a procedure to correct Keratoconus, a rare eye disease.

Cell transplant therapy could be a treatment for leading cause of blindness and last updated 2021-02-15 15:29:09-05 CINCINNATI, Ohio — Donuts have a way of pleasing the senses. Chocolate, blueberry, glazed – you can almost taste them just by looking at them. What if you couldnt see the wide selection? Cheri McDaniel, who started Ms. Cheris Donuts in 2009, has been losing her eyesight more and more every year. "Peoples faces from across the room, if I dont know who you are, I cant see ...

Published: Jan 27, 2021   PLEASANTON, Calif., Jan. 27, 2021 /PRNewswire/ -- Surface Ophthalmics, Inc., a pharmaceutical company focused on the development and commercialization of innovative therapeutics for ocular diseases, today announced that the first patient has been dosed in the Phase II clinical trial for its investigational product SURF-100 (mycophenolate sodium and betamethasone sodium phosphate in Klarity ® vehicle) for the treatment of chronic dry eye disease.   SURF-100 u...